We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Vectura unveiled positive results from two phase 2 studies evaluating the ability of young children and toddlers with asthma to use its nebulized inhaler, suggesting that its VR647 budesonide system could reduce delivery times and lower steroid doses comp